CDK1 and prostate carcinoma: However, the difference between the mRNA levels of EGFR, CDK1, SMAD4, CD44, GSK3B, SRC, PPARG, STAT1 and BRCA1 in prostate cancer and normal tissue were not statistically significant (Supplementary Fig. 2).